Delivery Order SPE2DB22D3501-SPE2DB24FWW31

Award Date 9/5/24
Potential Completion Date 9/6/24
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,026.03 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The contract is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, with a period of performance through July 15, 2024. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to...
The U.S. Defense Logistics Agency (DLA) awarded a Firm-Fixed Price Delivery Order contract worth $7,890.00 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 held by Amerisourcebergen with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
The U.S. Defense Logistics Agency (DLA) awarded a $5,523 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4565440991 - MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The award has an ultimate completion date of August 14, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $18,358.36 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the procurement of the drug MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. This award is part of AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, a $999,999,999 contract vehicle that provides a comprehensive range of pharmaceutical products and...
The Defense Logistics Agency (DLA) awarded a $3,419.00 Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office division, a leading pharmaceutical distributor. The contract is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a prescription medication. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this IDC,...
The U.S. Defense Logistics Agency (DLA) awarded a $14,348.71 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division to provide the prescription medication MOUNJARO (12.5 mg/0.5 ml pen, 0.5 ml). This order falls under Amerisourcebergen's existing $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which enables the DLA to efficiently procure a wide range of pharmaceutical products and medical supplies for military...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract, valued at $10,344.01, is for the provision of the medication MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. This delivery order contract does not have a set-aside designation and is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distributor AmerisourceBergen Corporation. The $14,525.34 contract is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. This delivery order falls under a larger indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, which has a potential value of up to...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The $3,156.00 firm fixed-price contract has an ultimate completion date of April 23, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025 to provide...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $4,269.99 to Amerisourcebergen Drug Corp, a division of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of the pharmaceutical product MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, with a completion date of February 16, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FWW31
    Delivery Order

The U.S. Defense Logistics Agency (DLA) has awarded a delivery order contract worth $2,630.00 to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a prescription medication. This delivery order is placed under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which provides a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has an ultimate completion date of September 6, 2024 and is a firm fixed-price contract. This award does not have a set-aside designation.

Generated 12/5/24, 9:21 AM